Spinocerebellar ataxia type 29
MONDO:0007298Spinocerebellar ataxia type 29 (SCA29) is a rare subtype of autosomal dominant cerebellar ataxia type I (ADCA type I) characterized by very slowly progressive or non-progressive ataxia, dysarthria, oculomotor abnormalities and intellectual disability.
Also known as: SCA29, congenital nonprogressive spinocerebellar ataxia, spinocerebellar ataxia 29, congenital nonprogressive, spinocerebellar ataxia type 29, ACV, aplasia of cerebellar vermis, cerebellar ataxia early-onset nonprogressive, cerebellar ataxia, congenital nonprogressive, autosomal dominant
19 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Can intense walking training help brain injury patients walk better?
Symptom relief Not yet recruitingThis study looks at whether high-intensity walking training can help people with cerebellar damage (a part of the brain that controls balance and coordination) improve their walking ability. Twenty participants will either do intense walking exercises or standard training. The go…
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New study hopes to unlock secrets of rare brain condition in children
Knowledge-focused Not yet recruitingThis observational study will follow 50 children aged 5 to 8 with non-progressive congenital ataxia, a rare condition that affects movement and coordination. Researchers will use detailed exams, brain scans, and genetic testing to better understand the disorder and its impact on …
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
AI vs. experts: can a computer judge speech as well as a human?
Knowledge-focused Not yet recruitingThis study will compare how well an AI program (Blings) measures speech clarity in 40 adults with speech disorders from stroke or other neurological conditions. Two speech therapists will also rate the same speech samples. The goal is to see if the AI can reliably replace or assi…
Sponsor: Pusan National University Yangsan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC